177
Participants
Start Date
November 30, 2023
Primary Completion Date
December 30, 2025
Study Completion Date
June 30, 2026
Transjugular Intrahepatic Portosystemic shunt
The experimental device is a class III implanted shunt device, which will be used to create a shunt between intrahepatic and portosystemic to reduce portal hypertension.
RECRUITING
Fujian Provincial Hospital, Fuzhou
RECRUITING
The first affiliated hospital of Guangzhou Medical University, Guangzhou
RECRUITING
Shanghai Public Health Clinical Center, Shanghai
RECRUITING
First Hospital of Shanxi Medical University, Taiyuan
Enlight Medical Technologies (Shanghai) Co., Ltd
INDUSTRY